Task-oriented Training Versus Group Circuit Training in Children With Quadriplegic Cerebral Palsy (NCT07420244) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Task-oriented Training Versus Group Circuit Training in Children With Quadriplegic Cerebral Palsy
36 participantsStarted 2026-03-01
Plain-language summary
Cerebral palsy is a common neurodevelopmental disorder that affects movement, posture, and functional abilities in children. This randomized controlled trial focuses on comparing the effects of task-oriented circuit training and group circuit training on functional performance and functional capacity in children with quadriplegic cerebral palsy. Outcomes will be measured using the Gross Motor Function Measure (GMFM-88) and the Activities Scale for Kids-Capability version (ASK-C). The findings of this study may help identify effective rehabilitation strategies for improving functional outcomes in children with cerebral palsy.
Who can participate
Age range
7 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children diagnosed with spastic quadriplegic cerebral palsy.
* Age between 7 and 12 years.
* Gross Motor Function Classification System (GMFCS) level II or III.
* Both genders.
* Lower limb spasticity graded between 1 and 1+ on the Modified Ashworth Scale.
* Ability to understand and follow simple instructions.
* No serious or recurrent medical complications.
Exclusion Criteria:
* Presence of fixed orthopedic deformities affecting balance or movement.
* Visual, auditory, vestibular, or perceptual deficits.
* History of seizures or epilepsy.
* Orthopedic surgery or botulinum toxin injections within the past 6 months.
* Participation in other structured rehabilitation programs during the study period.
* Presence of neuromuscular disorders other than cerebral palsy.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Functional Performance
Timeframe: From baseline to the end of treatment at 16 weeks
2
Functional Capacity
Timeframe: From baseline to the end of treatment at 16 weeks